FDA Inspection
Pharmaceutical Specialties, Inc.Pharmaceutical Specialties, Inc. – FDA Inspection, May 3, 2019
Record Details
This FDA Inspection record concerns Pharmaceutical Specialties, Inc., with an inspection on May 3, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 480a4535-0bb5-4262-841f-4eff1aa484d6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1091169
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pharmaceutical Specialties, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 15, 2025 | VAI | Minneapolis District Office | Drug Quality Assurance |
| February 26, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pharmaceutical Specialties, Inc.
- FDA Inspection 1274911 - 2025-08-15
- FDA Inspection 867840 - 2014-02-26
- FDA Inspection 564154 - 2009-02-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.